AstraZeneca Continues to Divest Assets, Takes Stake in Mereo BioPharma With New Deal

  • Post author:
  • Post category:BioPharma

Astra signed a licensing deal with Mereo BioPharma to out license the oral inhibitor of neutrophil elastase to the smaller Mereo.
Source: BioSpace